Literature DB >> 12779049

Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of celecoxib through human skin.

G Yener1, U Gönüllü, M Uner, T Değim, A Araman.   

Abstract

The aim of this study was the comparison of three different formulations (gel, o/w emulsion, oleagenous cream) and two penetration enhancers (oleic acid and menthol) as vehicle systems for celecoxib in respect of release and penetration through excised human skin in vitro. The influence of the vehicle on the release rate was studied in vitro using a cellulose acetate membrane. The release rate could be increased by up to 6.5 and 2.5 times with gel and o/w emulsion compared to oleagenous cream respectively. Further in vitro penetration measurements using human skin on Franz diffusion cells were performed with and without oleic acid and menthol as enhancers. It was shown that the penetration rate is strongly dependent upon the enhancer type and concentration but not on the vehicle itself and could be increased by 48% when 5% oleic acid was used in oleagenous cream. In all formulations tested, celecoxib was released and penetrated into human skin more quickly and to a greater extent from the gel formulations. There is no topical formulation available of celecoxib and its penetration properties through human skin have not been investigated. Since celecoxib creates some gastrointestinal disturbances, topical formulations of celecoxib preferably in gel form including 5% oleic acid could be suggested as an alternative.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12779049

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  4 in total

1.  Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies.

Authors:  Eder André Estracanholli; Fabíola Silva Garcia Praça; Ana Beatriz Cintra; Maria Bernadete Riemma Pierre; Marilisa Guimarães Lara
Journal:  AAPS PharmSciTech       Date:  2014-07-01       Impact factor: 3.246

2.  Skin Delivery and Irritation Potential of Phenmetrazine as a Candidate Transdermal Formulation for Repurposed Indications.

Authors:  Ying Jiang; Kevin S Murnane; Sonalika A Bhattaccharjee; Bruce E Blough; Ajay K Banga
Journal:  AAPS J       Date:  2019-05-31       Impact factor: 4.009

3.  Topical chemoprevention of skin cancer in mice, using combined inhibitors of 5-lipoxygenase and cyclo-oxygenase-2.

Authors:  L Fegn; Zhi Wang
Journal:  J Laryngol Otol       Date:  2009-02-16       Impact factor: 1.469

4.  A Study on Improvement of Solubility of Rofecoxib and its effect on Permeation of Drug from Topical Formulations.

Authors:  Madhur Kulkarni; Mangal Nagarsenker
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.